Doyle Anthony — SEC Form 4 filings

SEC reporting owner CIK 1808688. 3 Form 4 filings on record with FilingPulse; latest filed 2024-12-23.

Transaction summary — filings shown

Covers all 3 filings on record, filed 2024-05-15 to 2024-12-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
BIOCRYST PHARMACEUTICALS INC (BCRX)Chief Financial Officer31 leg · 36,300 sh · $202,1914

Form 4 filings — Doyle Anthony

FiledFormIssuerReported transactionsSource
2024-12-234BIOCRYST PHARMACEUTICALS INC (BCRX)Grant/award (A): 120,700 @ $0 · Tax withholding (F): 2,461 @ $7.39 · Grant/award (A): 250,100 (derivative) @ $0EDGAR
2024-12-174BIOCRYST PHARMACEUTICALS INC (BCRX)Tax withholding (F): 7,890 @ $7.53EDGAR
2024-05-154BIOCRYST PHARMACEUTICALS INC (BCRX)Purchase (P): 36,300 @ $5.57EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1808688 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →